Forte Biosciences (FBRX) Reports Q2 Loss of $0.42/sh

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Forte Biosciences (FBRX) Reports Q2 Loss of $0.42/sh

Forte Biosciences, Inc. Announces Second Quarter 2023 Results and Provides Business Update

August 14, 2023 4:01 PM EDT

DALLAS--(BUSINESS WIRE)-- Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a biopharmaceutical company focused on autoimmune and autoimmune-detailed diseases, today announced second quarter 2023 results and provided a business update.

Second Quarter 2023 Business Highlights

We were pleased to announce earlier in the month that FB-102 had demonstrated... More